The American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), and the American Society of Hematology (ASH) have convened an expert panel to develop an evidence-based guideline entitled “Requirements for Laboratory Workup of Lymphoma.” The draft recommendations were developed by the expert panel after a systematic review of more than 6,000 peer-reviewed titles with the aim of answering the overarching clinical question “What are the specimen requirements for accurate diagnosis for patients in whom lymphoma is being considered?” A list of disclosures and references included for data extraction is available for review.
All stakeholders—including pathologists, pathologist assistants, hematologists/oncologists, clinicians, laboratory personnel, quality managers in laboratories, hospitals or health systems, vendors, patient advocacy group representatives, and patients—are encouraged to provide feedback on the draft recommendations to ensure they are clinically sound, practical, and implementable.
During the open comment period, the expert panel will conduct a refresh of the literature search to include newer articles published since the initial literature search was conducted. The expert panel will consider all comments which will be used to finalize the recommendations along with the additional evidence from the literature refresh. The final recommendations will appear in the guideline manuscript.
Reviewing and commenting on the draft recommendations should take approximately 30+ minutes to complete. We thank you in advance for your participation.
Steven H. Kroft, MD, ASCP Co-chair
Cordelia E. Sever, MD, CAP Co-chair
Matthew Cheung, MD, ASH Co-chair
Clinical care providers – are members of the clinical care team providing treatment to lymphoma patients which include physicians, oncologists, pathologists, radiologists, primary care physician.